Sino-US Symposium on Natural Health Products

Botanicals are widely used worldwide. According to the stated "intended use", plants and related ingredients can be used in traditional Chinese medicine, health food, and dietary supplements registered in the United States and other countries.In the context of the global supply chain, one of the challenges facing the industry is how to achieve regulatory compliance in the international trade of plant ingredients used as medicines, health food or dietary supplements.
On June 18, 2019, Sino-US natural health products symposium was held at SNIEC, Shanghai. At the symposium, experts focused on how to ensure the quality, safety and efficacy of dietary supplements, health foods and herbal medicines in the global supply chain through the Chinese and American pharmacopoeia public standards.The one-day workshop will gather industry associations, industry and academic stakeholders to address regulatory challenges and regulatory compliance requirements in a global supply chain environment.
2026-09-05
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
6th Drug Safety Symposium 2026 to Focus on “Beyond Algorithms & Assumptions, What Actually Matters in Pharmacovigilance”
-
Easy insomnia may be qi deficiency deficiency, eat more of these 8 kinds of food to qi and blood to make up for it
-
Researches Shows that Plant Extract Industry are Soaring All Over the World at the End of the Year 2021
-
Pingmei Shenma Group holds 2019 strategic customer Symposium
-
The biggest annual event in chemical safety will be held in Suzhou in October.
-
Morning Light Group holds doctoral symposium, achieving great achievements
-
The Symposium on Promoting the Implementation of China's Energy Transition
-
Wanhua Chemical and Xingfa Group Jointly Develop 5.32 Billion Yuan Phosphate Mine
-
Ingredion Agrees to Acquire Tate & Lyle for $3.6 Billion, Reshaping the Global Specialty Ingredients Market
-
Novo Nordisk’s Oral Wegovy Wins EU Approval as Weight-Loss Competition Shifts from Injections to Pills
Recommend Reading
-
AstraZeneca Pays Up to $1.5 Billion for Global Rights to Chinese Lung Cancer Drug
-
Is Evonik’s Massive Global Expansion of Hydroxyl-Terminated Polybutadiene (HTPB) a Technological Ambition — or a Geopolitical Gamble?
-
BASF to Sell Optical Brighteners Business to Catexel
-
Mitsubishi Chemical Announces Expansion of Advanced Carbon Fiber Production Capacity in Japan and the United States
-
Dow Sounds the Alarm in Southeast Asia: Polymer MDI Prices Jump by $200/ton Amid Market Turbulence
-
Weak Demand Pressures Adipic Acid Prices in China
-
Insufficient Cost and Demand Support; PTA Prices to Weaken
-
Sulfate of Ammonia Market Prices Stop Falling and Rise (7.13-7.20)
-
Geopolitical Conflicts Drive a Surge in Phthalic Anhydride Prices in China
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center